163 related articles for article (PubMed ID: 12213119)
21. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey.
Cheng Z; McKellar QA; Nolan A; Lees P
J Vet Pharmacol Ther; 1996 Apr; 19(2):149-51. PubMed ID: 8735424
[No Abstract] [Full Text] [Related]
22. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
Williams RJ; Smith JA; Boudinot FD; Knight AP
Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
[TBL] [Abstract][Full Text] [Related]
24. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
Landuyt J; Delbeke FT; Debackere M
J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
[TBL] [Abstract][Full Text] [Related]
25. Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling.
Landoni MF; Cunningham FM; Lees P
Am J Vet Res; 1995 Jun; 56(6):786-94. PubMed ID: 7653889
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics and pharmacokinetics of carprofen in the horse.
Lees P; McKellar Q; May SA; Ludwig B
Equine Vet J; 1994 May; 26(3):203-8. PubMed ID: 8542839
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat.
Arifah AK; Landoni MF; Lees P
J Vet Pharmacol Ther; 2003 Apr; 26(2):139-50. PubMed ID: 12667184
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
Cheng Z; Welsh E; Nolan A; McKellar QA
Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of phenylbutazone in camels.
Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
[TBL] [Abstract][Full Text] [Related]
32. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats.
Eltom SE; Guard CL; Schwark WS
J Vet Pharmacol Ther; 1993 Jun; 16(2):141-51. PubMed ID: 8345564
[TBL] [Abstract][Full Text] [Related]
33. A pharmacodynamic and pharmacokinetic study with vedaprofen in an equine model of acute nonimmune inflammation.
Lees P; May SA; Hoeijmakers M; Coert A; Rens PV
J Vet Pharmacol Ther; 1999 Apr; 22(2):96-106. PubMed ID: 10372594
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
Aliabadi FS; Lees P
J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
[TBL] [Abstract][Full Text] [Related]
35. Age-dependent pharmacokinetics of phenylbutazone in calves.
Volner Z; Nouws JF; Kozjek F; van Ginneken CA; Primozic S
Vet Q; 1990 Apr; 12(2):98-102. PubMed ID: 2363243
[TBL] [Abstract][Full Text] [Related]
36. Influence of oxytetracycline on carprofen pharmacodynamics and pharmacokinetics in calves.
Brentnall C; Cheng Z; McKellar QA; Lees P
J Vet Pharmacol Ther; 2013 Aug; 36(4):320-8. PubMed ID: 22913421
[TBL] [Abstract][Full Text] [Related]
37. Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation.
Lees P; Higgins AJ
Am J Vet Res; 1986 Nov; 47(11):2359-63. PubMed ID: 3466561
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals.
Ferre PJ; Laroute V; Braun JP; Cazaux J; Toutain PL; Lefebvre HP
J Anim Sci; 2006 May; 84(5):1295-301. PubMed ID: 16612034
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.
Sidhu PK; Landoni MF; Aliabadi MH; Toutain PL; Lees P
J Vet Pharmacol Ther; 2011 Aug; 34(4):376-87. PubMed ID: 21091727
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats.
Sidhu PK; Landoni MF; Lees P
Res Vet Sci; 2006 Feb; 80(1):79-90. PubMed ID: 16005916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
